The company says the return to a ‘new normal’ post-lockdown provides a significant opportunity for practices to apply a renewed focus to preventative healthcare, recommending parasiticides as a way to improve animal welfare and generate practice revenue, which is vital for economic recovery.
Caitrina Oakes, Vetoquinol Managing Director UK and Ireland, said: “With many pet owners spending more hours than ever with their pets during lockdown, companion animal parasiticides have never been more important – making Profender and Drontal highly relevant in the current environment.”
She added: “It’s a very challenging time for many veterinary practices as everyone adapts to the post-COVID world. I’m looking forward to seeing how the passion and ambition we bring to our brands helps Profender and Drontal to grow and helps us to better serve the needs of the veterinary community, both now and in the future.”
Up to date information on the brands and their distribution can be found on the Vetoquinol website, www.vetoquinol.co.uk, by calling 01280 814500, or practices can contact their Vetoquinol Territory Manager directly.
For the trial, the company has partnered with Pennard Vets in Kent, where they're using Google Glass to transmit what the practitioner sees straight to the consulting experts at VetCT.
The remote VetCT specialist is able to view and remotely record, zoom, adjust lighting, annotate and send images back for the wearer of the glasses to view.
They are also able to discuss the case live with team in the clinic.
As part of the trial, images streamed via the glasses are being compared against those shot on a higher resolution mobile phone.
Director and Innovation Lead at VetCT, Julien Labruyère said: “We have a tremendous resource of specialist knowledge and expertise within our global team, and are exploring new ways to maximise the potential benefits of real-time clinical mentoring, teaching and case support.
"This first step we have taken with Google Glass marks the start of an exciting journey to make smart glasses technology useful to help vets in practice."
Caroline Collins, Director at Pennard Vets, said: “Trialling the glasses has been a fascinating exercise. We’re now looking at cases where we could see the most benefit from real-time specialist feedback and hands-free capability. It could be a real game-changer in some situations, for example with remote guidance of patient examinations or complex procedures.”
To learn more about VetCT visit www.vet-ct.com.
The Committee has been named after the Supplementary Royal Charter 2015 which broadened the functions of the RCVS and allowed for a more flexible approach when dealing with complaints about professional conduct.
The Charter Case Committee can resolve cases where the conduct of a veterinary surgeon or nurse has fallen far below the level of conduct expected of them, but not so far as to warrant a full, public Disciplinary Committee hearing.
The Committee can deal with such cases without the need for a public hearing and can give veterinary surgeons or nurses either a confidential or a public warning about their future conduct.
A warning issued by the Charter Case Committee does not affect the individual’s registration status or their right to practise.
Eleanor Ferguson, RCVS Registrar, said: “The establishment of the Charter Case Committee plays a vitally important role in balancing our statutory role of upholding professional conduct standards and protecting animal health and welfare and public confidence in the professions, with our mission to become a compassionate regulator.
“The Charter Case Committee Protocol allows for the alternative resolution of certain cases where a veterinary surgeon or veterinary nurse has engaged in behaviour that amounts to serious professional misconduct or has been convicted of an offence, but where it is not in the public interest for the matter to be referred to a hearing of the Disciplinary Committee because it is at the lower end of seriousness.
“The type of cases we envisage being dealt with by the Committee are those where the Code has been breached but where there is no ongoing risk to animal welfare or public confidence, and where the level of insight and personal reflection regarding their conduct is such that it can be resolved without the need for an onerous, stressful and expensive Disciplinary Committee hearing.
"We estimate that the CCC will deal with around 20 such cases per year.
“The most serious cases of professional misconduct will, of course, continue to be referred to Disciplinary Committee hearings.”
https://www.rcvs.org.uk/who-we-are/committees/charter-case-committee.
As part of the scheme, Linnaeus offers one-to-one mentoring, professional and clinical skills development in primary care practices across the UK as part of the scheme.
The group, which now has more than 3,000 employees, delivers all clinical training in-house through its network of specialists, referral clinicians, certificate holders and primary care clinicians.
The 2021 programme applications will remain open until the end of May, unless all positions are filled sooner.
Chloe Roberts, clinical and educational development manager at Linnaeus, said: “This will be the fourth cohort to join our GDP and we’re looking forward to building on the successes we have enjoyed over the last three years.
“This has been a challenging year for obvious reasons, so it has been extremely heartening to see our new vets rise to that challenge and continue their professional journeys with our support.
“We’re excited to hear from the next intake of new vets and look forward to supporting them in their transition to clinical practice and recognise the additional challenges they faced joining the profession in the midst of a global pandemic.”
For more information, visit graduates.linnaeusgroup.co.uk or www.instagram.com/linnaeusgdp.
The tracker, which Elanco produces with NADIS (National Animal Disease Information Service), highlights areas hit with blowfly strike in real-time, to provide a warning for farmers, veterinary surgeons and industry professionals.
The first reported incidents were in Hampshire, before spreading across Devon, West Sussex, and Buckinghamshire. Elanco says particularly severe cases include a flock in Dorset, in which 50% of a lamb group have been hit by blowfly strike. Latest reports are in northern England and some initial cases in Scotland.
The company says its blowfly risk forecast suggests that weather conditions from southern England and Wales to the Midlands mean that flies are now active, and females are laying eggs that could result in serious welfare and productivity issues.
Richard Wall, Professor of Zoology at Bristol University, said: "The timing and severity of blowfly strike is strongly influenced by the weather. This is a reminder to farmers that now is the time to act for early prevention. Delaying treatment not only costs the farm but risks the welfare and productivity of the flock."
Fiona Hutchings, Technical Vet at Elanco, said: "The costs of inaction when it comes to blowfly strike far outweigh the costs of protection. With 99% of farmers having suffered financial losses as a result of blowfly strike¹, the potential impact on your flock simply isn’t worth the risk. Farms need to take control — and take control early — by using a preventative IGR product with full fleece protection2."
Fiona added: "By the time symptoms show themselves, it’s often too late. It’s easy to overlook even one struck sheep, and blowfly strike can cause huge damage in very little time. In addition, using protection early reduces risk later in the season by ensuring a much lower fly count as the season progresses."
Ceva Animal Health has launched Marboxidin chewable tablets for dogs and cats for the treatment of micro-organisms susceptible to marbofloxacin, including skin and soft tissue infections (in cats and dogs), respiratory tract infections (in dogs and cats) and urinary tract infections (in dogs).
Containing marbofloxacin as its active ingredient, Marboxidin has a taste-masking lipid coating to ensure that its bitterness is not detected. In palatability trials over 90% of dogs and 80% of cats voluntarily consumed Marboxidin chewable tablets from the hand or in food1. Ceva says that Marboxidin is also very cost-effective, with an ongoing discount using the new CevaSave rebate scheme.
Marboxidin chewable tablets are available in three tablet sizes (5mg, 20mg and 80mg).
For further details, contact your Ceva Territory Manager or telephone the customer support team on (01494) 781510.
References
Elisa, pictured right next to Bill Oddie, is the founding member of a craft conservation charity called Blankets for Baby Rhinos. In less than three years the group has amassed a Facebook community of around 3,500 members, primarily knitters, crocheters and crafters, to make blankets and other items to supply to wildlife centres taking in orphaned and sick rhinos in Africa, as well as other wildlife threatened by poaching.
Originally from South Africa, Johannesburg-born Elisa had planned to work as a vet treating wildlife but found herself working in small animal practice in Cape Town before moving to the UK.
Still, colleagues and friends often told her of the injuries they saw inflicted on rhinos targeted for the illegal trade in their horns, so she and a friend decided to help.
After building a following and supplying thousands of blankets for a growing number of wildlife orphanages in Africa, she wanted to harness the enthusiasm of members to help meet the other practical needs of the centres, as well as helping rangers and dogs working in anti-poaching units.
Now a registered charity, members supply all kinds of equipment including animal feed, medicine and veterinary supplies to a wide list of centres, as well as food for anti-poaching dogs while continuing to run appeals which crafters can assist with. Currently they are asking knitters to knit hats, scarves and blankets in black or dark colours for rangers, so they can keep warm at night without being spotted by poachers.
James Sawyer, UK Director of IFAW, said: "Elisa’s pioneering approach to harnessing practical public support to help rhinos and other rescued African wildlife is really impressive and she is a great example of animal welfare in action. We hope her efforts will inspire the next generation of animal welfare and conservation campaigners. She is a very deserving winner of IFAW’s Vet of the Year Award."
Researchers at the University of Saskatchewan's Western College of Veterinary Medicine (WCVM) are carrying out a survey of equine practitioners to discover, amongst other things, just how common Cushing's disease is internationally.
The 16-question survey was launched this month and will be available for a further six months at www.wcvm.com/veterinarians/cushings_survey.php
Dr. James Carmalt, an equine surgeon and associate professor in the WCVM's Department of Large Animal Clinical Sciences said: "Our objective is to determine the true prevalence of Cushing's disease worldwide, because until now, previous surveys were only based in the U.S."
Dr. Carmalt is also a PhD student in equine neurophysiology through the western Canadian veterinary college's Department of Veterinary Pathology. He and his graduate supervisor, veterinary pathologist Dr. Andrew Allen, are beginning to explore a new treatment methodology for equine Cushing's disease.
Researchers will use practitioners' responses to the brief survey to determine the incidence of the disease and the most common treatment protocols being used by practitioners in countries around the world. They also want to evaluate the need for developing new treatment methodologies. Dr Carmalt said: "Right now, the only available treatment for Cushing's disease requires daily dosing of medications for the rest of the horse's life. It's onerous, time consuming and a huge management challenge.
"If the responses from this survey reflect our impression that practitioners need a new option to offer their clients, our ultimate goal is to develop a one-time treatment for the disease so daily medications for Cushing's disease become unnecessary."
For more information about the Cushing's disease survey for equine practitioners, please contact Dr. James Carmalt (james.carmalt@usask.ca). As part of the survey, practitioners can also provide their email addresses if they wish to receive a copy of the survey results.
The RCVS has released the results of a survey which has found that increasing numbers of graduates over the last five years have had little impact on veterinary job prospects.
The survey was carried out for the RCVS by the Institute for Employment Studies, which asked the last five years' UK graduates who have registered with the College how long it took them to find work, how long they stayed in their first jobs, and why they moved on.
The online survey, which achieved a 43% response rate (1,354 responders), found that an average of 94% of graduates seeking a role in clinical practice obtained work within six months of starting to look.
The actual figure ranged from a high of 96% in 2008 to a low of 92% in 2010, and did not change significantly over the five years under consideration, despite UK graduate numbers increasing by around a quarter during the same period (from 650 in 2007, to 819 in 2012). Meanwhile, the College has registered an average of 618 overseas graduates annually during this time.
The survey did show that it was taking graduates slightly longer to secure their posts, with a shift from 85% securing work under three months in 2008, to 71% in 2012.
The results seem to suggest some small differences in the time taken for men and women to find their first jobs, with men finding jobs slightly quicker, although the vast majority of both genders found veterinary work.
Jacqui Molyneux, RCVS President said: "After the announcement from the University of Surrey that it will be opening a new vet school in the near future, there was a great deal of discussion amongst the profession about how easily new graduates could find employment. I undertook to get some real facts and am pleased to find that the picture is not as gloomy as predicted.
However, Jacqui said she was concerned that there has been a slight increase in the proportion of respondents who left their first position after a relatively short period of time. Amongst 2012 graduates, over 40% of those who had left their first position did so within three months of starting work. However it must be stressed that only 18% of those answering the survey who graduated in 2012 had already left their first position. Jacqui said: "Although the turn-over in first jobs seems to be, in part, due to an increase in temporary posts, I am saddened to see that the most commonly-cited reason for graduates leaving their first job was lack of support from their employers or professional colleagues.
"This is an area that we, as a profession, must address. As I have told all the students I have admitted to the College, their first jobs will influence their whole careers, and getting adequate support is probably the single most important factor. Meanwhile, it is heartening to see that nearly all of those moving on have obtained further employment."
Although the survey was sent to all those UK graduates who had registered with the RCVS within the last five years, the contact details for those who had subsequently de-registered may not have been up to date, which may mean that those who had de-registered because they could not find work were not well represented. However, the College says it thinks it is more likely that these individuals would have switched to the 'non-practising' category.
A summary of the headline survey results will be available at www.rcvs.org.uk/publications. The full findings, which also looked at the time taken to complete the Professional Development Phase and the type and location of work sought, will be available in due course.
Dechra says Equisolon is the only registered oral prednisolone powder that alleviates the inflammation and clinical parameters associated with severe equine asthma, previously known as recurrent airway obstruction (RAO).
Equisolon Jar contains 180g of powder and comes with a measuring spoon.
One scoop is enough to treat 150kg bodyweight at a dose of 1mg/kg and therefore one jar can treat a 600kg horse for 10 days.
Equisolon was previously available as a box of 10 x 9g pre-measured sachets with one sachet sufficient to treat a 300kg horse and a box contained enough sachets to treat a 600g horse for five days.
Alana McGlade, national sales manager at Dechra said: “The addition of Equisolon Jar to the Equisolon range provides vets with the flexibility to choose between a jar featuring a convenient measuring spoon and a box of easy to dose pre-measured sachets
www.dechra.co.uk/products/horse/prescription
The workshop will be hosted by Renzo Di Florio (pictured right), veterinary advisor at Ceva Animal Health.
The session will look at the impact of Q Fever in the UK, outlining how it affects cattle health and reproductive performance and productivity.
It'll also cover identification of the disease and diagnosis, and prevention through vaccination and treatment.
For further information and to book tickets for TotalDairy, visit www.totaldairy.com (Ceva can offer a 10% discount on the purchase of tickets to the event using the code CEVA10).
Equine infectious anaemia (EIA) has been detected in a horse in Northumberland following importation from the Netherlands, Defra confirmed today.
The premises is currently under restriction and the infected horse will be humanely destroyed in line with existing regulations. The other horses on the premises are currently subject to epidemiological investigation.
The horse arrived in a group of six horses originating in the Netherlands and all have been tested for EIA as part of routine post-import testing. The other five horses in the group have all tested negative.
Chief Veterinary Officer Nigel Gibbens said: "This again shows the success of our post import testing regime. These were apparently healthy horses carrying a notifiable disease that we are keen to keep out of Great Britain. After considering the risk I have decided to take appropriate action and humanely destroy this horse."
Meanwhile, equine welfare charity World Horse Welfare is sending out an urgent plea to all horse owners across the UK and mainland Europe to work together in order to stop the increasing threat from this and a number of other diseases.
According to the charity, this case comes only eight months after the discovery of two horses suffering from the disease, which is notifiable, in Wiltshire. Those horses had been transported across Europe from Romania before being imported into the UK. Since the end of August alone, there have been new outbreaks reported in Northern France (directly linked to horses imported from Romania), the Dordogne area, and Germany.
World Horse Welfare Chief Executive Roly Owers said: "While World Horse Welfare welcomes the news that Defra has acted so promptly in dealing with this case, today's news is extremely concerning and demonstrates the changing environment we're living in. This is a real warning to us that we're sailing far too close to the wind. The concerning question is where these horses came from given that Holland to date has not reported a case of EIA.
"With more and more horses moving across Europe, including the significant trade in low value animals, not just slaughter animals, we're facing an increasing threat from the spread of disease. EIA is endemic in both Romania and Italy; Romania being one of the largest exporters and Italy being the largest importer of horses for slaughter in Europe. In spite of the legal requirement for health certification before exporting horses from Romania, which were tightened in June 2010, there continues to be cases of EIA across Europe.
"World Horse Welfare advises owners to undertake rigorous checks when buying a horse from abroad and is discouraging anyone from importing Romanian horses. Owners should also ensure that any horse they buy or that comes on to their yard has a passport, is checked for a microchip and that isolation and biosecurity measures are strictly followed for any new entry onto the yard. If this disease spreads across the UK it could have catastrophic effects on our horse population. Whether it's a child's pony or Cheltenham Gold Cup winner, disease does not discriminate."
The video has now been published on Youtube, from where veterinary practices might like to share it with clients on their own websites, by email or on their Facebook page.
In the video, Cat Henstridge MRCVS explains how from November, in the event of no deal, pet owners will need to have visited their vet 4 months before travel and had their pet vaccinated against rabies. They will then need to return for a blood test 30 days later, wait at least 3 months after that test before travel, and get an animal health certificate no more than 10 days before travel. In addition their animal needs to be microchipped.
Defra says owners should also be advised to visit gov.uk and search 'pet travel' for any updates.
Christine Middlemiss, UK Chief Veterinary Officer, said: "This is a reminder for pet owners of our practical and straightforward advice for pet travel if the UK were to leave the EU in a no-deal situation."
To watch and share the video: https://www.youtube.com/watch?v=8Ckhv5YS7Mw.
The company has won the Institute of Student Employers (ISE) 'Best Graduate Onboarding and Induction Activities Programme.' (Dear god. Not to take anything away from Vets4Pets' considerable achievement, but is it just me that finds it like fingernails on a blackboard when people take a perfectly serviceable preposition like 'on board' and turn it into a verb?).
Gordon Dunn, People Director at Vets4Pets, said: “As a leading UK veterinary employer, we view it as our personal responsibility to fully prepare graduates at the beginning of their career. This includes, but isn’t limited to, ensuring they are equipped with the right skills and behaviours to forge their own individual career pathway, and increase the chances of them remaining in the profession.
"The induction and onboarding of our graduates forms the lynchpin of our programme, and clearly sets out what is to come. Being recognised for the work we’re doing to develop the next generation of veterinary talent is a huge celebration for us and is a testimony to the investment made and hard work over the last few years to develop and evolve a world-class development programme. We’re extremely proud to be recognised for this achievement.”
No word on the absolute number of 'concerns', but they included:
Jennie Jones, Head of VCMS and Partner at Nockolds Resolution (pictured right), said: "The COVID-19 pandemic and subsequent lockdown period has impacted many pet owners and veterinary practices. The increased use of remote consultations, and online and remote prescription services has been a great help to many during this time, but it also has its challenges as we all adapt to different ways of working. At the VCMS, we are well-equipped to take on complaints that eventuate in these circumstances, drawing on our past experience with prescription-related grievances and their resolution."
During 2018-19, the VCMS concluded 88% of complaints mediated using the ADR process developed by Nockolds.
Nockolds says it anticipates a rise in prescription-related complaints, and welcomes communication from practices and clients regarding these or any other vet-related complaints. Visit: http://www.nockolds.co.uk
Mr Beveridge had been removed from the Register following a disciplinary hearing in May 2013 in which he was found guilty of disgraceful conduct in a professional respect with the Committee finding that he had treated clients badly, kept inadequate clinical records, was dishonest in his dealings with the College and that animals in his care were placed at risk. He subsequently appealed to the Privy Council but this was later withdrawn, resulting in him being formally removed from the Register in March 2014.
He first applied to be restored to the Register in 2015 but his application was refused by the Disciplinary Committee at a hearing in November 2015. At the time the Committee found him unfit for restoration to the Register because, following his removal, his veterinary medicines account had been used on an unauthorised basis to order prescription-only veterinary medicines, which reflected a "cavalier attitude to practice". Furthermore, the Committee found that he had not fully accepted the Committee’s original findings, had made inadequate effort in regards to engaging in continuing professional development (CPD) and also considered the seriousness of the original findings.
At the opening of his second hearing Mr Beveridge, who represented himself, sought to address the concerns that the Disciplinary Committee had outlined upon refusing his first application for restoration. Regarding his acceptance of the original findings, the Committee heard that he now apologised "unreservedly for his failings that led to erasure of his name from the Register" and the Committee considered that he had demonstrated a significant change in attitude from the previous restoration hearing where he had not fully accepted the reasons for being removed.
In considering issues of public protection the Committee also accepted that Mr Beveridge, until his original Disciplinary Committee hearing, had an unblemished professional record and had run a successful small animal practice for over 30 years. It considered numerous client testimonials as well as a petition signed by 600 clients from 2013.
The Committee also considered that there was no risk to the future welfare of animals in the event of Mr Beveridge being restored to the Register, noting the testimonials and references to satisfactory care and treatment given by Mr Beveridge to his patients.
Regarding CPD, Mr Beveridge produced evidence before the Committee that he had attended courses run by the North American Veterinary Community (NAVC) and the British Small Animal Veterinary Association (BSAVA). The Committee accepted that he had made "considerable progress" in terms of CPD.
In concluding the hearing Judith Way, chairing the Committee and speaking on its behalf, said: "It is the judgement of the Committee that the conduct which resulted in the applicant’s name being removed from the Register is unlikely to be repeated. The applicant has satisfied the Committee that he is fit to be restored to the Register."
The kit contains the ergonomically designed Henke-Sass Wolf injector with an adjustable dose selector, five single piece Intranasal RSP nozzles – with ‘luer’ lock attachment, which supports easier removal, cleaning and/or replacement – and instructions for use.
For more information, contact your local MSD Animal Health account manager.
Belfast-based Des Thompson MRCVS was presented with the first ever RCVS Queen's Medal by Her Majesty at Buckingham Palace this afternoon.
Des, pictured right showing off the new medal with his wife Rosalie, received two separate nominations for the medal, both citing his decades of active involvement in veterinary politics which includes being president of the RCVS, the British Small Animal Veterinary Association (BSAVA), the Society of Practising Veterinary Surgeons (SPVS) and the Northern Ireland Veterinary Association, among other organisations.
Also cited was his willingness to help other members of the profession, particularly young vets at the beginning of their careers, through his involvement with organisations such as the Young Vet Network in Northern Ireland and the Veterinary Benevolent Fund.
The Queen's Medal was launched in 2013, with the approval of Her Majesty as Patron of the RCVS, and is now the highest award that can be bestowed upon a veterinary surgeon in recognition of a particularly outstanding contribution to the profession. In receiving the medal, Des was joined by Professor Stuart Reid, current RCVS President, Colonel Neil Smith, immediate past President, and Gordon Hockey, RCVS Registrar.
Des said: "It was a complete honour and a wonderful experience to be received by Her Majesty at Buckingham Palace today, and I'm thrilled to have been awarded the RCVS Queen's Medal. Her Majesty was interested to hear about Northern Ireland, and the fact that I've been practising there since I qualified."
Equine obesity is a growing problem not just in the UK but around the world. The debate explored how various sectors of the equestrian industry see the challenges faced by people who are struggling to manage their horse’s weight. It included the views of equine vet Lucy Grieve, horse owner Helen Gale, livery yard owner and coach Beth Maloney, nutritionist Liz Bulbrook, competition judge David Ingle and equine welfare officer Penny Baker.
The session was chaired by equine vet and nutrition specialist Professor Pat Harris with the support of Dr Tamzin Furtado, a social scientist with a special interest in human behaviour change for animals.
The panellists shared their views on what they believed to be the blocks for horse owners in recognising obesity and addressing the problem.
They identified the importance of empowering owners and working with them to make step by step changes with the support of a reliable and trusted team including vet, nutritionist, yard owner and farrier.
Lucy said: “Vets are in unique and privileged position to provide an achievable and effective tailor-made strategy for individual horses.
"We must all learn to overcome avoidance and engage recognise, accept and understand, and tailor a solution.”
Helen added: “Owners need to be able to recognise and acknowledge that their horse has a weight problem and be motivated to take action. Communication is key. It’s important for others to understand why you are following the advice form vets and other experts and how they can best help."
There was recognition that a bespoke approach is needed for every horse, owner and situation. Some livery owners may face challenges in changing management practices and peer pressure on a yard may prevent people implementing intake restriction measures such as a grazing muzzle or restricted turnout.
Beth said: “Peer pressure can be daunting and there can be a lack of confidence that you are doing the right thing."
Communication and proactive signposting to reliable advice and scientific information were identified as pivotal, not only in helping to identify weight changes but also to build horse owners’ knowledge and confidence. This would build a clearer understanding of the calorific value of feeds and of grass and forage, what constitutes a balanced diet, the importance of regular exercise and weight monitoring, being able to identify the difference between fat and muscle and being familiar and comfortable with the range of weight control tactics, such as grazing muzzles, restricted grazing and track systems.
The language used was also identified as important; gauging the needs and response of the individual and asking the owner what they think, would be more effective than using potentially inflammatory language - for example choosing the phrase ‘fat pad’ rather than the terms ‘overweight’ or ‘obese’.
Lucy said: “If we are all being really honest with ourselves obesity is neglect. I doubt many vets would walk away from an emaciated horse or an infected wound or a cloudy eye so why are we so willing to walk away from these ticking time bombs which are actually a real welfare issue as the animal is potentially at risk of losing their life?”
You can buy tickets for a replay of the debate for £5, here: https://www.eventbrite.co.uk/e/the-great-weight-debate-equine-playback-tickets-138080533593
The 29th National Equine Forum will be held online on Thursday 4th March 2021. Tickets will be available in February 2021. If you'd like to be notified when they become available, you can subscribe here: https://www.nationalequineforum.com/subscribe/
The new programme, which starts in May 2021, will address the fundamental principles underlying cardiac disease, discuss common presentations and review current diagnostic and therapeutic techniques.
Modules are delivered using a range of blended learning techniques, including interactive online lessons, supported by notes and videos.
While studying, delegates will have a module tutor – a recognised veterinary Specialist in their field - and a dedicated programme tutor, who works with individual delegates to support them through the programme.
Delegates can also choose three optional practical attendance sessions covering ECGs, thoracic radiography and echocardiography.
The programme offers a route through to achieving academic qualifications - General Practitioner Certificate (GPCert) and the Postgraduate Certificate (PgC), in partnership with the International School of Veterinary Postgraduate Studies (ISVPS) and Harper Adams University. Gaining a PgC enables delegates to apply to RCVS for Advanced Practitioner status in the subject.
Course Director Kieran Borgeat BSc BVSc MVetMed CertVC DipACVIM DipECVIM-CA MRCVS, said: "Improve International’s Cardiology DL programme features a diverse array of speakers from a variety of backgrounds, who will bring the latest information about veterinary cardiology to delegates. Our module leaders are world experts in their field so bring a thorough and uniquely engaging approach to the course material. Being able to discuss the topic with them and other course delegates online during each module of teaching during a two-year, in-depth course is a fantastic opportunity to connect with the topic as never before."
David Babington MRCVS, Business Development Director at Improve International, said: “Our cardiology programme has been designed to equip delegates with all of the skills and knowledge they need to confidently investigate, diagnose and treat cardiac patients.
“As we start to look ahead to a time beyond lockdowns, many veterinarians are taking stock and considering the next step in their career. For some, an additional qualification may be part of their plan. By offering a distance learning solution, we can ensure that, wherever in the world they are in practice, they have the opportunity to develop their clinical skills and achieve a postgraduate qualification.”
Registration information can be found here: https://www.improveinternational.com/uk/course/pgc-gpcert-small-animal-cardiology-distance-learning/
The book contains 40 chapters of articles about clinical techniques, diagnostic pathways and management approaches published in Companion between 2016 and 2020.
Editor of Companion, Samantha Taylor said: “At Companion we strive to produce well-illustrated, practical articles to help vets and VNs in practice face the day-to-day challenges of a varied caseload. We hope this collection meets our aims by covering a variety of clinical problems from hypercalcaemia in cats to managing the snuffly rabbit, from Leishmaniasis to lymphoma and many more.
Ian Ramsey (BSAVA Senior Vice President) said: “This collection represents a unique body of well-illustrated work prepared by experts from all around the UK and beyond. I would like to thank them all on behalf of BSAVA members and readers of this book for taking the time and care to develop these resources for their colleagues around the world.”
Samantha added: “Whether kept on the shelf for when needed or thumbed through over a cup of tea, we hope that within the pages of this new volume you find a useful tip or technique that helps.”
The How to…collected articles from BSAVA Companion (2016–2020), 3rd edition has been published as a BSAVA member loyalty reward gift for those eligible veterinary members who renew their membership this year.
The book is also available to buy from the BSAVA website www.bsava.com/shop priced at £20.
For the study, researchers reviewed the anonymised medical records of 2,040 chelonia on the College's VetCompass database.
94.26% were recorded as tortoises, 3.63% terrapins and 2.11% turtles.
The most common tortoise species were Hermann’s tortoise, Horsfield’s tortoise and Mediterranean spur-thighed tortoise, while the most common terrapin species were musk turtle and yellow belly slider.
The study found that the most common disorders in tortoises were beak abnormality (17.68%), overgrown nails (11.91%) and shell abnormality (9.67%), while the most common disorders in terrapins were top and bottom shell abnormalities (13.51%).
The researchers say that most of these disorders are externally visible making them easier to recognise and diagnose, however they also often correspond with inappropriate husbandry and can be related to internal diseases that are harder to identify and diagnose.
The average age of death in the study was found to be 7.32 years, which is below the expected lifespan of most species of tortoise, suggesting that many are dying prematurely.
Dr Jessica May Hornby, exotic veterinary surgeon and lead author of the study, said:
“This research has provided us with a base to start to understand what veterinarians are currently seeing in practice and therefore give an insight into the health of the chelonian population.
"People are no longer only keeping the more common species of pets, such as dogs and cats, so this data is vital to understanding where and how owners and veterinarians need further support and training to ensure these brilliant little guys get the veterinary care they need, especially when many should easily be outliving us!”
Reference
Photo: www.depositphotos.com
George won the Best Medicine Award for: 'Predictors of clinically significant bleeding in dogs with severe thrombocytopenia'.
Kathryn won the Best Practitioner Award for: 'Reflecting on first opinion clinical improvement project across 39 UK vet practices to support diagnosis and management of OA.'
Sebastian won the Best Surgery Award for: 'Complications and outcomes following surgical management of Achilles Tendon injury'
The Best Student Award was won by Michelle Demkova for: 'Lifting the flap on otitis externa in dogs under primary veterinary care in the UK – the VetCompass view'.
In addition, Clare Jones RVN won the Best Poster Award for: 'Confidence with CPR within Veterinary Professionals. Would standardised CPR training help confidence within Veterinary Professionals?'
Submissions for the 2025 Clinical Abstracts will open on 9th September 2024, and will close on 18th October, and those chosen will present their work at BSAVA Congress 2025, in Manchester on 20th – 22nd March.
https://www.bsavacongress.com/register-interest
The company surveyed 1979 pet owners last December and found the main reason they didn’t take their cat to the vet more often was because the animal appeared to be healthy and therefore didn’t need medical attention.
The second biggest barrier to more regular vet visits was cost. Although almost half of the cat owners surveyed had pet insurance, almost a quarter said cost prevented them from taking their cat to the vet more often.
Despite there being 760 cat-friendly clinics across the UK and Ireland, 13% percent of owners said the stress put them off making more frequent trips to the vet.
If they were unable to take their cat to the vet, 40% said they would arrange for a vet home visit, 29% said they would search for information online and 26% would turn to friends and family for advice.
The survey also found that 11% of owners believed that their cat was overweight. However, according to a 2018 study, 39% of cats are overweight in the UK, which would suggest that over a quarter of cat owners surveyed were unaware that their cat was above a healthy weight.
Dechra Veterinary Products has launched Ketodale, an anti-inflammatory injection for cattle, horses and swine.
Ketodale contains the non-steroidal anti-inflammatory drug ketoprofen 100mg/ml. It is indicated for use in cattle and swine for diseases associated with inflammation, pain or fever. In cattle these include respiratory diseases, mastitis, osteoarticular and muscular-skeletal disorders, such as lameness and arthritis, and to ease pain post parturition. Ketodale can be used to treat swine suffering from Mastitis Metritis Agalactia (MMA) Syndrome and respiratory tract infections.
In horses, Ketodale is indicated for diseases affecting the osteoarticular and muscular-skeletal system associated with pain and inflammation. These include naviculitis, arthritis and laminitis. It can also be used for post-surgical inflammation and symptomatic therapy of colic and fever.
Ketodale is available in 50ml and 100ml vials.
To coincide with the product's launch, Dechra is carrying out a direct marketing campaign. Practices can take advantage of a special launch offer where they can purchase four vials and get a fifth free. The offer is available for a limited period only.
To find out more about Ketodale, call Dechra on 01743 441 632 or visiting www.dechra.com